Home/Pipeline/Real-time Multi-Cancer Early Risk Assessment

Real-time Multi-Cancer Early Risk Assessment

Solid Tumors (12+ common types)

PreclinicalActive

Key Facts

Indication

Solid Tumors (12+ common types)

Phase

Preclinical

Status

Active

Company

About miRoncol

AI‑enhanced microRNA blood test for early multi‑cancer risk assessment.

View full company profile

Therapeutic Areas